Safety of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRiTE)Eric Hedrick, Axel Grothey, Suprith Badarinath et al.|Journal of Clinical Oncology|2006Cited by 87